Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.47 |
| ▸ | MAPT | P10636 | 5/20 | 0.47 |
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.44 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.41 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.41 |
| ▸ | PTPN12 | Q05209 | 1/20 | 0.41 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.41 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.40 |
| ▸ | TNKS | O95271 | 1/20 | 0.40 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15855169 | 1.00 | GPR3 (0.58) | GPR3ALDH1A1MAPTRAB9AHPGD | |
| SCHEMBL15836006 | 1.00 | GPR3 (0.58) | GPR3ALDH1A1MAPTRAB9AHPGD | |
| SCHEMBL15836021 | 1.00 | GPR3 (0.58) | GPR3ALDH1A1MAPTRAB9AHPGD | |
| SCHEMBL16582762 | 1.00 | GPR3 (0.58) | GPR3ALDH1A1MAPTRAB9AHPGD | |
| SCHEMBL15836018 | 1.00 | GPR3 (0.58) | GPR3ALDH1A1MAPTRAB9AHPGD | |
| SCHEMBL15855168 | 1.00 | GPR3 (0.58) | GPR3ALDH1A1MAPTRAB9AHPGD | |
| SCHEMBL15855442 | 1.00 | GPR3 (0.58) | GPR3ALDH1A1MAPTRAB9AHPGD | |
| SCHEMBL15855164 | 1.00 | GPR3 (0.58) | GPR3ALDH1A1MAPTRAB9AHPGD | |
| SCHEMBL15836056 | 0.98 | GPR3 (0.56) | GPR3ALDH1A1MAPTRAB9AHPGD | |
| SCHEMBL15836059 | 0.98 | GPR3 (0.56) | GPR3ALDH1A1MAPTRAB9AHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220416178-A1 | COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS | IDEMITSU KOSAN CO.,LTD. (JP) | 2022-12-29 | — | — | US | disclosed |
| US-11535637-B2 | Compound and organic light emitting element comprising same | LG CHEM, LTD. (KR) | 2022-12-27 | — | — | US | disclosed |
| US-20200216475-A1 | COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2020-07-09 | — | — | US | disclosed |
| US-9978952-B2 | Fused heterocyclic aromatic derivative, organic electroluminescence element material, and organic electroluminescence element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2018-05-22 | — | — | US | disclosed |
| US-9978952-B2 | Fused heterocyclic aromatic derivative, organic electroluminescence element material, and organic electroluminescence element using same | IDEMITSU KOSAN CO., LTD. (JP) | 2018-05-22 | — | — | US | disclosed |
| EP-2757101-A1 | FUSED HETEROCYCLIC AROMATIC DERIVATIVE, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL, AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME | Idemitsu Kosan Co., Ltd (JP) | 2014-07-23 | — | — | EP | disclosed |
| US-20140175419-A1 | FUSED HETEROCYCLIC AROMATIC DERIVATIVE, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL, AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. | 2014-06-26 | — | — | US | disclosed |
| US-20140175419-A1 | FUSED HETEROCYCLIC AROMATIC DERIVATIVE, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL, AND ORGANIC ELECTROLUMINESCENCE ELEMENT USING SAME | IDEMITSU KOSAN CO., LTD. | 2014-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220416178-A1 | COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS | PIEZO1, TMEM109, SLC39A14 | GPR3 3681/4885ALDH1A1 196/4885MAPT 1926/4885 |
| US-11535637-B2 | Compound and organic light emitting element comprising same | NR2E3, NR4A2, NR2C2 | GPR3 430/4885ALDH1A1 1206/4885MAPT 3576/4885 |
| US-20200216475-A1 | COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | NR2E3, NR4A2, NR4A1 | GPR3 219/4885ALDH1A1 1241/4885MAPT 4066/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.